» Articles » PMID: 36715986

Predicting Microbe-drug Associations with Structure-enhanced Contrastive Learning and Self-paced Negative Sampling Strategy

Overview
Journal Brief Bioinform
Specialty Biology
Date 2023 Jan 30
PMID 36715986
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: Predicting the associations between human microbes and drugs (MDAs) is one critical step in drug development and precision medicine areas. Since discovering these associations through wet experiments is time-consuming and labor-intensive, computational methods have already been an effective way to tackle this problem. Recently, graph contrastive learning (GCL) approaches have shown great advantages in learning the embeddings of nodes from heterogeneous biological graphs (HBGs). However, most GCL-based approaches don't fully capture the rich structure information in HBGs. Besides, fewer MDA prediction methods could screen out the most informative negative samples for effectively training the classifier. Therefore, it still needs to improve the accuracy of MDA predictions.

Results: In this study, we propose a novel approach that employs the Structure-enhanced Contrastive learning and Self-paced negative sampling strategy for Microbe-Drug Association predictions (SCSMDA). Firstly, SCSMDA constructs the similarity networks of microbes and drugs, as well as their different meta-path-induced networks. Then SCSMDA employs the representations of microbes and drugs learned from meta-path-induced networks to enhance their embeddings learned from the similarity networks by the contrastive learning strategy. After that, we adopt the self-paced negative sampling strategy to select the most informative negative samples to train the MLP classifier. Lastly, SCSMDA predicts the potential microbe-drug associations with the trained MLP classifier. The embeddings of microbes and drugs learning from the similarity networks are enhanced with the contrastive learning strategy, which could obtain their discriminative representations. Extensive results on three public datasets indicate that SCSMDA significantly outperforms other baseline methods on the MDA prediction task. Case studies for two common drugs could further demonstrate the effectiveness of SCSMDA in finding novel MDA associations.

Availability: The source code is publicly available on GitHub https://github.com/Yue-Yuu/SCSMDA-master.

Citing Articles

BANNMDA: a computational model for predicting potential microbe-drug associations based on bilinear attention networks and nuclear norm minimization.

Liang M, Liu X, Li J, Chen Q, Zeng B, Wang Z Front Microbiol. 2025; 15:1497886.

PMID: 39911712 PMC: 11794793. DOI: 10.3389/fmicb.2024.1497886.


MKAN-MMI: empowering traditional medicine-microbe interaction prediction with masked graph autoencoders and KANs.

Ye S, Wang J, Zhu M, Yuan S, Zhuo L, Chen T Front Pharmacol. 2024; 15:1484639.

PMID: 39512819 PMC: 11540998. DOI: 10.3389/fphar.2024.1484639.


Dynamic category-sensitive hypergraph inferring and homo-heterogeneous neighbor feature learning for drug-related microbe prediction.

Xuan P, Xu Z, Cui H, Gu J, Liu C, Zhang T Bioinformatics. 2024; 40(9).

PMID: 39292557 PMC: 11441325. DOI: 10.1093/bioinformatics/btae562.


Heterogeneous biomedical entity representation learning for gene-disease association prediction.

Meng Z, Liu S, Liang S, Jani B, Meng Z Brief Bioinform. 2024; 25(5).

PMID: 39154194 PMC: 11330343. DOI: 10.1093/bib/bbae380.


OGNNMDA: a computational model for microbe-drug association prediction based on ordered message-passing graph neural networks.

Zhao J, Kuang L, Hu A, Zhang Q, Yang D, Wang C Front Genet. 2024; 15:1370013.

PMID: 38689654 PMC: 11058190. DOI: 10.3389/fgene.2024.1370013.